These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 23318502)

  • 21. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
    Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
    Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major contributions of comparative endocrinology to the development and exploitation of the incretin concept.
    Conlon JM; Patterson S; Flatt PR
    J Exp Zool A Comp Exp Biol; 2006 Sep; 305(9):781-6. PubMed ID: 16902971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoproteolysis by isolated membrane peptidases reveal metabolic stability of glucagon-like peptide-1 analogs, exendins-3 and -4.
    Thum A; Hupe-Sodmann K; Göke R; Voigt K; Göke B; McGregor GP
    Exp Clin Endocrinol Diabetes; 2002 May; 110(3):113-8. PubMed ID: 12012270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Truncated Glucagon-like Peptide-1 and Exendin-4 α-Conotoxin pl14a Peptide Chimeras Maintain Potency and α-Helicity and Reveal Interactions Vital for cAMP Signaling in Vitro.
    Swedberg JE; Schroeder CI; Mitchell JM; Fairlie DP; Edmonds DJ; Griffith DA; Ruggeri RB; Derksen DR; Loria PM; Price DA; Liras S; Craik DJ
    J Biol Chem; 2016 Jul; 291(30):15778-87. PubMed ID: 27226591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and structural, biochemical, and pharmaceutical characterizations of bile acid-modified long-acting exendin-4 derivatives.
    Son S; Chae SY; Kim CW; Choi YG; Jung SY; Lee S; Lee KC
    J Med Chem; 2009 Nov; 52(21):6889-96. PubMed ID: 19827752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preproglucagon derived peptides and thyrotropin (TSH) secretion in the rat: robust and sustained lowering of blood TSH levels in exendin-4 injected animals.
    Malendowicz LK; Nowak KW
    Int J Mol Med; 2002 Sep; 10(3):327-31. PubMed ID: 12165809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig.
    Deacon CF; Pridal L; Klarskov L; Olesen M; Holst JJ
    Am J Physiol; 1996 Sep; 271(3 Pt 1):E458-64. PubMed ID: 8843738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1.
    Andersen NH; Brodsky Y; Neidigh JW; Prickett KS
    Bioorg Med Chem; 2002 Jan; 10(1):79-85. PubMed ID: 11738609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreas and liver uptake of new radiolabeled incretins (GLP-1 and Exendin-4) in models of diet-induced and diet-restricted obesity.
    Seo D; Faintuch BL; Aparecida de Oliveira E; Faintuch J
    Nucl Med Biol; 2017 Jun; 49():57-64. PubMed ID: 28365524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of synthetic exendin-4 in human plasma in vitro.
    Chen J; Yu L; Wang L; Fang X; Li L; Li W
    Protein Pept Lett; 2007; 14(1):19-25. PubMed ID: 17266646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design of a humanized glucagon-like peptide-1 receptor agonist antibody.
    Zhang Y; Zou H; Wang Y; Caballero D; Gonzalez J; Chao E; Welzel G; Shen W; Wang D; Schultz PG; Wang F
    Angew Chem Int Ed Engl; 2015 Feb; 54(7):2126-30. PubMed ID: 25556336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design of α-helix-stabilized exendin-4 analogues.
    Rovó P; Farkas V; Stráner P; Szabó M; Jermendy A; Hegyi O; Tóth GK; Perczel A
    Biochemistry; 2014 Jun; 53(22):3540-52. PubMed ID: 24828921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery.
    Yang PY; Zou H; Chao E; Sherwood L; Nunez V; Keeney M; Ghartey-Tagoe E; Ding Z; Quirino H; Luo X; Welzel G; Chen G; Singh P; Woods AK; Schultz PG; Shen W
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4140-5. PubMed ID: 27035989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A radioimmunoassay for LY315902, an analog of glucagon-like insulinotropic peptide, and its application in the study of canine pharmacokinetics.
    Chou JZ; Place GD; Waters DG; Kirkwood JA; Bowsher RR
    J Pharm Sci; 1997 Jul; 86(7):768-73. PubMed ID: 9232514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-oligourea hybrids analogue of GLP-1 with improved action in vivo.
    Fremaux J; Venin C; Mauran L; Zimmer RH; Guichard G; Goudreau SR
    Nat Commun; 2019 Feb; 10(1):924. PubMed ID: 30804332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glycosylation on biodistribution of radiolabeled glucagon-like peptide 1.
    Watanabe A; Nishijima K; Zhao S; Tanaka Y; Itoh T; Takemoto H; Tamaki N; Kuge Y
    Ann Nucl Med; 2012 Feb; 26(2):184-91. PubMed ID: 22187312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of ¹¹¹in-labelled exendin-4 derivatives containing different meprin β-specific cleavable linkers.
    Jodal A; Pape F; Becker-Pauly C; Maas O; Schibli R; Béhé M
    PLoS One; 2015; 10(4):e0123443. PubMed ID: 25855967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of exenatide elimination and its in vivo and in vitro degradation.
    Copley K; McCowen K; Hiles R; Nielsen LL; Young A; Parkes DG
    Curr Drug Metab; 2006 May; 7(4):367-74. PubMed ID: 16724926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.